On March 13, Senators Barbara Boxer (D-CA) and Mark Kirk (R-IL) introduced the Regenerative Medicine Promotion Act of 2014, which would create a Regenerative Medicine Coordinating Council within the Department of Health & Human Services, call for a detailed assessment of federal activities in regenerative medicine, and compare progress of national programs in this area to other countries.
Regenerative medicine aims to augment, repair, replace or regenerate organs and tissue that have been damaged by disease, injury, or even the natural aging process.
PAN CEO Amy Comstock Rick was quoted in the Alliance for Regenerative Medicine’s (ARM) press release announcing the Act.
“Regenerative medicine offers hope for millions of Americans living with debilitating conditions or diseases,” Amy said in the release. “By establishing national priorities and coordination of federal agencies around regenerative medicine, this Act paves the way for our families to benefit from breakthrough scientific developments, secures a leading role for the U.S. in the global medical economy of the future, and creates possibilities for new solutions to the healthcare financing crisis.”